TIDMBPCR

RNS Number : 0897Z

BioPharma Credit PLC

16 September 2020

BIOPHARMA CREDIT PLC

(THE "COMPANY")

Appointment of New Director

The Company is pleased to announce the appointment of Rolf Soderstrom as a non-executive Director, with effect from 16 September 2020.

Rolf has over 30 years' strategic and operational experience in finance including M&A, fundraisings and disposals and is currently Senior Independent Director of Ergomed plc and Chair of its Audit and Risk Committee and External Independent Director of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange, both of which are companies in the life sciences sector. From 2008 to 2018, Mr Soderstrom was CFO of BTG plc and helped drive the successful transformation of the company into a fully integrated global manufacturing and sales organisation focused on specialist healthcare. He was previously Divisional Finance Director at Cobham Plc and Director of Corporate Finance at Cable & Wireless Plc and qualified as a chartered accountant at PricewaterhouseCoopers.

Publicly quoted directorships held by Mr Soderstrom within the last five years are as follows:

 
 Company                   Position 
 Sosei Group Corporation   External Independent Director and 
                            member of audit committee 
 Ergomed plc               Non-executive Director, Senior Independent 
                            Director, Chair of the Audit and Risk 
                            Committee and member of Remuneration 
                            and Nomination Committees 
 BTG plc                   Chief Financial Officer

There are no other details required to be disclosed under LR 9.6.13R (2) to (6) of the Financial Conduct Authority Listing Rules.

16 September 2020

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAFZGMLVKNGGZM

(END) Dow Jones Newswires

September 16, 2020 02:05 ET (06:05 GMT)

Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Biopharma Credit Charts.
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Biopharma Credit Charts.